Cali Holan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 Maple St, Woodruff, WI 54568 Phone: 715-356-8920 |
Dr. Molly Kathryn Pilarski, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 240 Maple St, Woodruff, WI 54568 Phone: 715-356-8000 |
Frederick Knoch, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 240 Maple St, Woodruff, WI 54568 Phone: 715-356-8920 |
Jennie A Leach, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 240 Maple St, Woodruff, WI 54568 Phone: 715-356-8000 |
James Mark Richards, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 Maple St, Woodruff, WI 54568 Phone: 715-356-8920 |
Heath J Meyer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 Maple St, Woodruff, WI 54568 Phone: 715-356-8920 |
Maria Tillman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 240 Maple St, Woodruff, WI 54568 Phone: 715-356-8000 |
News Archive
Neuroscientists have provided clear visual evidence that a region of the human brain known as the ventral striatum kicks in during decision-making to weigh the costs versus the benefits of making a physical effort.
Vitrolife: Growth in local currency was 13 percent. Sales amounted to SEK 217 (207) million, corresponding to an increase of 4 percent in SEK. Operating income before research and development costs increased by 11 percent and amounted to SEK 58 (53) million.
"Africa's economy expanded by 4.7 percent in 2010 and is expected to maintain similar growth over the next two years," according to the U.N.'s World Economic Situation and Prospects 2011 report, which was released Tuesday in the Ethiopian capital Addis Ababa, Deutsche Presse-Agentur/M&C reports.
Indianapolis interventional medical device maker NICO Corporation and Toronto-based 3D visualization leader Synaptive Medical announced today at the Congress of Neurological Surgeons Annual Meeting that they have joined forces to integrate their innovative technologies for brain surgery.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London. The study's principal investigators were Drs. Eric Bateman, Mary Bateman and Paul Potter.
› Verified 9 days ago